Drug Profile
Spironolactone oral suspension - CMP Pharma
Alternative Names: CaroSpirLatest Information Update: 13 Sep 2023
Price :
$50
*
At a glance
- Originator CMP Pharma
- Class Antihormones; Antihypertensives; Heart failure therapies; Pregnenes; Vascular disorder therapies
- Mechanism of Action Aldosterone antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Heart failure; Hypertension; Oedema
Most Recent Events
- 28 Apr 2022 No recent reports of development identified for phase-I development in Heart-failure(In volunteers) in India (PO, Suspension)
- 28 Apr 2022 No recent reports of development identified for phase-I development in Hypertension(In volunteers) in India (PO, Suspension)
- 28 Apr 2022 No recent reports of development identified for phase-I development in Oedema(In volunteers) in India (PO, Suspension)